Skip to main content
OpenTrials
Completed

NCT Number: NCT04673032

Radiofrequency (RF) Ablation Prospective Outcomes Study

The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems in the treatment of patients diagnosed with pain

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Pain, Chronic Chronic Pain Neurologic Manifestations Pain Pathological Conditions, Signs and Symptoms Signs and Symptoms

Age range

0 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

ZNA Hoge Beuken, Antwerp, Belgium

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Key Inclusion Criteria:

  • Study candidate is scheduled to be treated with a commercially approved Boston Scientific RF system for pain per local Directions for Use (DFU)
  • Signed a valid, IRB/EC/REB-approved informed consent form

Key Exclusion Criteria:

  • Meets any contraindications per locally applicable Directions for Use (DFU)
  • Currently diagnosed with cognitive impairment, or exhibits any characteristic, that would limit study candidate's ability to assess pain relief or to complete study assessments

Treatment and study plan

Radiofrequency Ablation

Device

Radiofrequency Ablation for treatment of chronic pain

Primary outcomes

  1. Patient Global Impression of Change (PGIC)

    Time frame: 12-months post-procedure

    Using the Patient Global Impression of Change (PGIC) Scale, subjects will rate themselves as: very much improved; much improved; minimally improved; no change; minimally worse; much worse; or very much worse compared with Baseline

Other outcomes

  1. Responder Rate

    Time frame: 12-months post-procedure

    Percentage of subjects with a 30 percent or greater reduction from Baseline in targeted pain intensity

Sponsors and collaborators

Lead sponsor

Boston Scientific Corporation

Industry

Registry information

Acronym: RAPID

Important dates

Study start
2020
Primary completion
2025
Study completion
2025
First posted
Dec 17, 2020
Registry last updated
Apr 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.